Immunovative Therapies Ltd.

Immunovative Therapies Ltd. is a leading biotechnology company focused on next-generation immunotherapy. Specializing in off-the-shelf, non-genetically altered, neo-antigen-based, in-situ cancer vaccines, Immunovative Therapies Ltd. is dedicated to advancing innovative solutions in the field of cancer treatment.

Located at Malha Technological Park, Building 1, Jerusalem, Israel 9695101, IL, Immunovative Therapies Ltd. operates with a commitment to excellence and cutting-edge research. The company provides drug depot management, blood donor center support, and clinical site management services, contributing significantly to the advancement of immunotherapy. Immunovative Therapies Ltd. collaborates with partners to design and build automated commercial-scale cell manufacturing pods and plug-and-play disposable sets, further enhancing its capabilities.

Immunovative Therapies Ltd. continues to drive progress in biotechnology through its dedicated efforts and strategic collaborations. The company’s unwavering focus on innovation positions it as a key player in the future of cancer immunotherapy. We are actively working to expand our data with the support of the company’s management. To the manager of Immunovative Therapies Ltd., we invite you to create a customized and exclusive company showcase and product listing on our platform to highlight your groundbreaking work.